Start-up focuses on nerve imaging
Nervonix, a medical R&D company headquartered in Bozeman, MT, is cultivating technology that generates noninvasive 2D images of peripheral nerves. The images might ultimately be used to identify the location of nerves, providing the basis for pain
Nervonix, a medical R&D company headquartered in Bozeman, MT, is cultivating technology that generates noninvasive 2D images of peripheral nerves. The images might ultimately be used to identify the location of nerves, providing the basis for pain diagnosis and management by anesthesiologists, surgeons, and other clinicians, according to the company. A portable device is being designed to deliver real-time, high-resolution nerve images from a patient's bedside or the operating table. Nervonix is collaborating with Battelle Memorial Institute to develop the technology into a viable product, which could be commercially available as early as mid-2004, according to Nervonix. The company is now looking for commercial partners, OEMs, and distributors to assist in its development and marketing efforts.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
